National Association for Proton Therapy
To educate stakeholders about the clinical benefits of proton therapy, ensure patient choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance appropriate and cost-effective utilization of proton therapy.
About National Association for Proton Therapy
The National Association for Proton Therapy (NAPT) is a U.S.-based nonprofit membership and advocacy organization established in 1990 that represents proton therapy centers, clinicians, patient advocates, and industry partners. NAPT’s work focuses on education, public policy and payer advocacy, member services, and patient-facing resources to expand access to proton therapy and support collaborative research. In addition to advocacy and policy engagement, NAPT runs an active resource center for patients and providers, hosts the annual National Proton Conference, convenes research forums, and operates a Foundation focused on education and research. Over the last 2–3 years NAPT has published member surveys and advocacy reports, produced toolkits for denials/appeals, and promoted multi‑center clinical data initiatives to strengthen the evidence base for proton therapy.
Notable achievements
Federal and State Advocacy Wins
NAPT has actively engaged policymakers and payers in recent years; notable 2024–2025 activities include influencing the timeline and language around the Radiation Oncology Case Rate initiative and supporting state-level coverage improvements such as Louisiana’s 2025 legislation requiring insurer coverage of proton therapy when recommended under clinical practice guidelines.
National Proton Conference
NAPT convenes the annual National Proton Conference (NPC), which in 2024–2025 highlighted practice-changing research, expanded patient-access discussions, and drew clinicians and industry leaders to share clinical innovations and operational best practices.
Support for Clinical Evidence (PCG Registry)
NAPT has supported collaborative research and clinical-data efforts, including public-facing promotion of the Proton Collaborative Group (PCG) proton therapy registry milestone (15 years of enrollment) and other multi‑center initiatives that strengthen outcome and toxicity reporting for proton therapy.
At a glance
- Total assets
- $317K
- Annual revenue
- $440K
- Tax status
- 501(c)(3)Public charity
- EIN
- 54-1519061
- Location
- Jacksonville, FL
- Website
- proton-therapy.org
- On Mahalo since
- May 2026
Financial figures from the IRS Business Master File, the IRS’s registry of tax-exempt organizations.
Recognition
Is this your organization?
Claim this page to keep it current — add your logo, publish campaigns, and reach the donors and advisors discovering you on Mahalo.
Claim this page